Please login to the form below

Not currently logged in
Email:
Password:

AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance

He joins the biopharma from Tang Capital Management

AVEO Oncology has appointed Dr Nikhil Mehta as senior vice president or regulatory and quality assurance, a role that will see him oversee all aspects of regulatory, quality and technical operations for the company’s portfolio.

Dr Mehta brings over 25 years’ experience in biotechnology and pharmaceutical industries to AVEO and most recently, Dr Mehta served as executive vice president and chief regulatory strategies at Tang Capital Management, where he was involved in establishing two biopharmaceutical companies.

Prior to Tang Capital, he served as global head of regulatory affairs at Baxalta and before that, he was vice president, global regulatory affairs, oncology, haematology, immunology and diagnostics at Merck & Co.

He has also held roles for Shire, Bristol-Myers Squibb and Hoffman-La Roche.

Michael Baily, president and chief executive officer, AVEO, said: “Dr Mehta brings to AVEO a depth of experience in regulatory affairs and oncology that we believe will be invaluable as we plan and advance our US registration strategy for tivozanib as a potential treatment for renal cell carcinoma.”

“I anticipate Dr Mehta’s integration into the AVEO team will be seamless and rapidly productive and we look forward to working with him.”

11th December 2017

From: Regulatory

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Biosimilars and beyond: innovating for improved patient outcomes
How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...